![Carol-Ann Ohmstede](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carol-Ann Ohmstede
Plus aucun poste en cours
Profil
Carol-Ann Ohmstede joined Trimeris, Inc. in 1998 as Vice President of Project Planning and was promoted to Vice President of Corporate Alliances and Project Planning in 2001.
Prior to joining Trimeris, she held various positions in the Research and Development Division of Burroughs Wellcome, Inc. and Glaxo Wellcome.
Dr. Ohmstede received a BA and a PhD in Biochemistry from the University of South Florida College of Medicine.
Anciens postes connus de Carol-Ann Ohmstede
Sociétés | Poste | Fin |
---|---|---|
Trimeris, Inc.
![]() Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
Formation de Carol-Ann Ohmstede
University of South Florida | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 1 |
---|---|
Trimeris, Inc.
![]() Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |